JPY 3735.0
(0.89%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 42.86 Billion JPY | 3.25% |
2022 | 41.52 Billion JPY | 6.3% |
2021 | 39.05 Billion JPY | 13.26% |
2020 | 34.48 Billion JPY | 17.87% |
2019 | 29.25 Billion JPY | -12.86% |
2018 | 33.57 Billion JPY | 3.29% |
2017 | 32.5 Billion JPY | -11.16% |
2016 | 36.58 Billion JPY | 12.21% |
2015 | 32.6 Billion JPY | 14.21% |
2014 | 28.55 Billion JPY | 14.19% |
2013 | 25 Billion JPY | 3.31% |
2012 | 24.2 Billion JPY | 11.34% |
2011 | 21.73 Billion JPY | 3.29% |
2010 | 21.04 Billion JPY | -9.31% |
2009 | 23.2 Billion JPY | 5.76% |
2008 | 21.94 Billion JPY | -16.14% |
2007 | 26.16 Billion JPY | -8.71% |
2006 | 28.65 Billion JPY | -2.35% |
2005 | 29.34 Billion JPY | 2.01% |
2004 | 28.77 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 38.36 Billion JPY | -10.5% |
2023 Q1 | 34.61 Billion JPY | -16.64% |
2023 Q4 | 42.86 Billion JPY | 31.86% |
2023 Q3 | 32.51 Billion JPY | -13.82% |
2023 FY | 42.86 Billion JPY | 3.25% |
2023 Q2 | 37.72 Billion JPY | 9.0% |
2022 Q1 | 34.45 Billion JPY | -11.78% |
2022 Q2 | 33.87 Billion JPY | -1.7% |
2022 Q3 | 35.9 Billion JPY | 6.01% |
2022 FY | 41.52 Billion JPY | 6.3% |
2022 Q4 | 41.52 Billion JPY | 15.63% |
2021 Q1 | 29.64 Billion JPY | -14.03% |
2021 Q2 | 29.16 Billion JPY | -1.64% |
2021 Q3 | 27.55 Billion JPY | -5.51% |
2021 Q4 | 39.05 Billion JPY | 41.75% |
2021 FY | 39.05 Billion JPY | 13.26% |
2020 FY | 34.48 Billion JPY | 17.87% |
2020 Q1 | 28.62 Billion JPY | -2.15% |
2020 Q3 | 25.58 Billion JPY | -8.07% |
2020 Q4 | 34.48 Billion JPY | 34.79% |
2020 Q2 | 27.83 Billion JPY | -2.78% |
2019 Q1 | 32.62 Billion JPY | -2.82% |
2019 Q2 | 31.16 Billion JPY | -4.5% |
2019 FY | 29.25 Billion JPY | -12.86% |
2019 Q4 | 29.25 Billion JPY | -5.36% |
2019 Q3 | 30.91 Billion JPY | -0.79% |
2018 FY | 33.57 Billion JPY | 3.29% |
2018 Q4 | 33.57 Billion JPY | 23.1% |
2018 Q3 | 27.27 Billion JPY | -7.49% |
2018 Q2 | 29.48 Billion JPY | 0.12% |
2018 Q1 | 29.44 Billion JPY | -9.42% |
2017 FY | 32.5 Billion JPY | -11.16% |
2017 Q2 | 31.68 Billion JPY | 6.8% |
2017 Q1 | 29.66 Billion JPY | -18.92% |
2017 Q4 | 32.5 Billion JPY | 12.92% |
2017 Q3 | 28.78 Billion JPY | -9.14% |
2016 Q3 | 31.6 Billion JPY | 8.02% |
2016 Q4 | 36.58 Billion JPY | 15.78% |
2016 FY | 36.58 Billion JPY | 12.21% |
2016 Q1 | 31.12 Billion JPY | -4.55% |
2016 Q2 | 29.25 Billion JPY | -6.0% |
2015 FY | 32.6 Billion JPY | 14.21% |
2015 Q2 | 25.89 Billion JPY | -9.26% |
2015 Q4 | 32.6 Billion JPY | 23.08% |
2015 Q3 | 26.49 Billion JPY | 2.33% |
2015 Q1 | 28.53 Billion JPY | -0.06% |
2014 Q3 | 26.13 Billion JPY | 9.81% |
2014 Q4 | 28.55 Billion JPY | 9.24% |
2014 Q1 | 25.47 Billion JPY | 1.88% |
2014 Q2 | 23.8 Billion JPY | -6.56% |
2014 FY | 28.55 Billion JPY | 14.19% |
2013 Q4 | 25 Billion JPY | 11.38% |
2013 Q1 | 23.31 Billion JPY | -3.66% |
2013 Q2 | 22.3 Billion JPY | -4.35% |
2013 Q3 | 22.44 Billion JPY | 0.65% |
2013 FY | 25 Billion JPY | 3.31% |
2012 Q3 | 21.03 Billion JPY | -4.75% |
2012 FY | 24.2 Billion JPY | 11.34% |
2012 Q4 | 24.2 Billion JPY | 15.07% |
2012 Q2 | 22.08 Billion JPY | -5.35% |
2012 Q1 | 23.33 Billion JPY | 7.33% |
2011 Q1 | 22.82 Billion JPY | 8.48% |
2011 Q3 | 20.81 Billion JPY | -7.68% |
2011 FY | 21.73 Billion JPY | 3.29% |
2011 Q2 | 22.54 Billion JPY | -1.25% |
2011 Q4 | 21.73 Billion JPY | 4.45% |
2010 Q1 | 23.07 Billion JPY | -0.56% |
2010 FY | 21.04 Billion JPY | -9.31% |
2010 Q4 | 21.04 Billion JPY | 2.02% |
2010 Q3 | 20.62 Billion JPY | -0.82% |
2010 Q2 | 20.79 Billion JPY | -9.87% |
2009 Q2 | 21.73 Billion JPY | 0.0% |
2009 Q4 | 23.2 Billion JPY | 1.49% |
2009 Q3 | 22.86 Billion JPY | 5.22% |
2009 FY | 23.2 Billion JPY | 5.76% |
2008 Q4 | 21.94 Billion JPY | -0.57% |
2008 Q3 | 22.06 Billion JPY | 0.0% |
2008 FY | 21.94 Billion JPY | -16.14% |
2007 FY | 26.16 Billion JPY | -8.71% |
2006 FY | 28.65 Billion JPY | -2.35% |
2005 FY | 29.34 Billion JPY | 2.01% |
2004 FY | 28.77 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -71.554% |
Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.453% |
Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 94.295% |
Shionogi & Co., Ltd. | 164.35 Billion JPY | 73.917% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -1162.688% |
Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -53.836% |
Eisai Co., Ltd. | 494.82 Billion JPY | 91.337% |
Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -750.556% |
Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 30.515% |
Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -39.037% |
Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -7.725% |
Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -37.91% |
Tsumura & Co. | 132.88 Billion JPY | 67.741% |
Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -7.733% |
Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -222.389% |
Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 84.398% |
Fuji Pharma Co., Ltd. | 44.15 Billion JPY | 2.921% |
Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 39.37% |
KYORIN Holdings, Inc. | 46.89 Billion JPY | 8.583% |
Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -512.138% |
Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -68.513% |
SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -426.496% |
MedRx Co., Ltd | 129 Million JPY | -33131.008% |
Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -1209.933% |
Solasia Pharma K.K. | 673 Million JPY | -6269.688% |
Modalis Therapeutics Corporation | 645.5 Million JPY | -6541.023% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -36.605% |
Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 73.86% |
Cyfuse Biomedical K.K. | 1.01 Billion JPY | -4138.733% |
Toho Holdings Co., Ltd. | 523.98 Billion JPY | 91.819% |
Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -516.598% |